| Active substance |
Somatropin |
| Also known as |
Orlistat |
| Blood pressure |
No significant impact |
| Chemical name |
Tetrahydrolipstatin |
| Dosage (medical) |
120 mg orally three times/day with each main meal containing fat |
| Dosage (sports) |
Not recommended for sports usage |
| Effects |
Reduces the absorption of dietary fats |
| Formula |
C29H53NO5 |
| Half-life |
1 to 2 hours |
| Hepatotoxicity |
Rare, but cases of severe liver injury reported |
| Lab Test |
Monitoring of liver enzymes may be advised |
| Main action |
Prevents the absorption of fats from the human diet, thereby reducing caloric intake |
| Side effects |
Oily spotting, flatulence, fecal urgency, soft stools, fecal incontinence |
| Storage conditions |
Store at 25°C (77°F), exceptions permitted to 15–30°C (59–86°F) |
| Substance class |
Lipase inhibitor |
| Trade name |
Orlistat, marketed under the trade name Xenical among others |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Active ingredient, IU |
10 |
| Release form |
Vial |
| 1 Vial, IU |
10 |
| Vials in the package, pcs |
1 |
| Manufacturer |
MGT |
